Veterinary Blog for Education, Careers, and Real Vet Life
Welcome to the Vet Candy Blog—your go-to destination for veterinary education, career growth, and real-life insights from the world of animal health.
From free RACE-approved CE courses and clinical updates to NAVLE prep and career advice, our content is designed for veterinarians, vet techs, and students who want to stay informed, inspired, and ahead in their careers.
Latest Veterinary News & Clinical Insights
FIV. Thoracotomy. Enucleation. Kidney Failure. HCM. This Cat Is Surviving All of It.
A routine heart murmur led to an early HCM diagnosis in a cat with multiple health challenges. Learn why proBNP testing and early detection matter.
What 14 Years in Vet Med Taught This Pet Owner About Never Giving Up
Kristyn Allen, who is currently a Senior IT Project Specialist at VCA, has worked in the veterinary field for 14 years. She is not a clinician, but she is something the profession produces in abundance: a person whose proximity to animal medicine has permanently recalibrated her capacity for commitment. When a big, fluffy, polydactyl shelter cat found wandering by a Good Samaritan caught her eye, it was love at first sight. She adopted him immediately.
Money, Mistrust, and Machines: What’s Shaping the Future of Vet Med
In the latest episode of Vet Candy Watch, Career Coach Vet Dr. Ashley Hopkins takes a closer look at the biggest conversations shaping the veterinary profession today. From economic realities to public perception and global innovation, this episode explores the issues that every veterinary professional should be paying attention to.
Veterinary cardiologist, Dr. Hayley McDonald Explains All about Felicyn CA-1
Felycin®-CA1 (sirolimus delayed-release tablets) is the first disease-modifying drug that can give hope to owners of cats with subclinical hypertrophic cardiomyopathy (HCM).Felycin®-CA1 is the first and only FDA conditionally approved once-weekly drug for the management of ventricular hypertrophy in cats with subclinical HCM.
Vet Candy Watch: Blue Pigs, Heavy Metal Water, and the Genetics of Feline HCM
This week on Vet Candy Watch, host Jeremiah Pouncey explores the latest veterinary science headlines that range from the genuinely puzzling to the downright bizarre. From unraveling the complicated genetics behind feline heart disease to investigating some truly strange blue pigs, this episode covers it all. Joining the conversation is veterinary cardiologist Dr. Hayley McDonald, who breaks down the science behind Felicyn CA-1 by PRN Pharmacal, the newly FDA conditionally approved drug for cats with hypertrophic cardiomyopathy.
Felycin®-CA1 is the First and Only Drug FDA Conditionally Approved for the Management of Ventricular Hypertrophy in Cats
PBI-Gordon Companies, Inc. the parent company of TriviumVet, which holds sole conditional approval from the FDA for Felycin®-CA1 (sirolimus delayed-release tablets) sold under the PRN Pharmacal brand of its affiliated company Pegasus, today announced the product is now available via licensed veterinarians nationwide. PBI-Gordon Companies, Inc. confirms that Felycin®-CA1 is the only drug currently legally marketed under conditional approval from the Food and Drug Administration (FDA) for the management HCM in cats.
Your Questions, Answered
-
Vet Candy welcomes relevant industry news, press releases, and high-quality content that provides value to veterinary professionals. Submissions should focus on clinical insights, innovation in animal health, or meaningful industry developments.
All submissions are reviewed by our editorial team to ensure they align with our content standards and audience interests. To inquire about opportunities, please contact our team through the website.
-
Vet Candy focuses on content that is educational, engaging, and relevant to veterinarians, vet techs, and veterinary students. This includes clinical updates, industry news, career insights, and expert perspectives that help professionals stay informed and grow in their careers.
-
Yes, Vet Candy offers opportunities for companies and organizations to share important updates, product news, and industry announcements through sponsored content, press features, and integrated campaigns—helping you reach a highly engaged veterinary audience.
-
You can reach us anytime via our contact page or email. We aim to respond quickly—usually within one business day.
-
Vet Candy is committed to providing content that is accurate, balanced, and relevant to veterinary professionals. Our editorial team works to maintain high journalistic standards by reviewing content for clarity, credibility, and educational value. We aim to present information in a way that reflects a range of perspectives within the veterinary industry.
-
We strive for accuracy in everything we publish, but if you notice an error or outdated information, we encourage you to reach out to our team. Vet Candy is committed to transparency and will review and update content as needed to ensure it remains accurate and reliable.
-
Yes, Vet Candy regularly reviews and updates content to maintain accuracy and relevance. When necessary, corrections or edits are made to ensure our content reflects the most current and reliable information available.